Results

Total Results: 1,187 records

Showing results for "weeks".

1181. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
      November 01, 2007 - PRIOR_MI OSCR 4109.002 Myocardial infarc PRIOR_MI OSCR 41090.001 History of myocardial infarction <8 weeks … Cardiac MI PRIOR_MI OSCR 41091.001 Myocardial infarction PRIOR_MI OSCR 4109.001 History of MI < 8 weeks … PRIOR_MI OSCR 41092.001 Recent MI < 8 weeks PRIOR_MI OSCR 411.001 MI (S/P) PRIOR_MI ICD9D 412 Old … of Myocardial infarction (MI) PRIOR_MI OSCR 412.003 Old MI PRIOR_MI OSCR 412.004 History of MI > 8 weeks … PRIOR_MI OSCR 412.005 Myocardial infarct (MI), OLD (>8 Weeks) PRIOR_MI OSCR 412.900 History of MI

1182. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
      August 22, 2008 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: January 22, 2010 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Effectiveness of Recombinant Human Growth Hormone in the Treatment of Cystic Fibrosis…

1183. CARDIOVASCULAR (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
      December 01, 2014 - lomitapide at a median dose of 40 mg per day reduced LDL-C concentrations by a mean of 50% at 26 weeks … escalate dosage gradually based on acceptable safety and tolerability to 10 mg daily after at least 2 weeks … Lomitapide reduced LDL-C concentrations by a mean of 50% at 26 weeks from baseline.

1184. Rotator-Cuff-Tear-Surveillance-140925 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
      February 01, 2014 - hyaluronate had improved function (Constant score) and pain (VAS) compared to patients on placebo 6 weeks … Limited passive rehabilitation (n=42; continuous passive motion exercise, self-passive exercise) 6 weeks … PL (6 weeks post-treat ment) Constant score: 79.24 ± 13.09 vs. 69.07 ± 13.29, p=0.0095 Pain (VAS):

1185. Ch 4-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
      January 01, 2010 - cardiovascular events, which would be over the preceding several years rather than, for instance, over the 2 weeks

1186. Antipsychotics-Adults Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_surveillance.pdf
      August 30, 2014 - Mortality SOE: Low – No differences found • Chlorpromazine vs. clozapine (2 studies) - at 52 and 208 weeks … change on mania rating scales and the number of patients who dropped out of the allocated treatment at 3 weeks … studies) - at 52 and 208 weeks other reviewer recommended examining • Haloperidol vs. aripiprazole (

1187. FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
      May 01, 2013 - In normal patients and those with gastroparesis, how reproducible are WMC studies performed 2 weeks … In normal patients and those with gastroparesis, how reproducible are WMC studies performed 2 weeks apart … In normal patients and those with gastroparesis, how reproducible are WMC studies performed 2 weeks … In normal patients and those with gastroparesis, how reproducible are WMC studies performed 2 weeks apart